BIO COVID-19 Therapeutic Development Tracker

BIO’s Industry Analysis Team has reviewed and annotated pipeline data from BioCentury and Biomedtrackerto create a granular, interactive view of the Covid-19 pipeline. The team has investigated each drug as to original inventor (company/country), mechanism of action and strategic approach, as well as de-duplicated multiple company and university programs for the same active ingredient (for example, hydroxychloroquine is counted only once).

The data below shows two key things:

  • Biopharma companies - particularly small biotech companies - are undertaking a monumental campaign to combat, and hopefully eradicate, Covid-19. 
  • Innovation is being led by U.S.-based companies.

This data will be updated monthly.

Receive the best resource for the biotech industry with Good Day BIO, the only daily newsletter at the intersection of biotech, politics and policy.